Analysts' Actions: GM DVA RIG STI ABT URBN

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Abbott Laboratories ( ABT) rated new Buy at Stifel. $40 price target. Company can generate solid and consistent earnings growth.

Atmel ( ATML) upgraded at Craig-Hallum from Hold to Buy, Craig-Hallum said. $9 price target. Market conditions are improving and the company will likely score some big content wins.

Progressive Waste Solutions ( BIN) upgraded to hold at TheStreet Ratings.

Coca-Cola Hellenic Bottling Company ( CCH) downgraded to hold at TheStreet Ratings.

Comerica ( CMA) downgraded at Citigroup to Sell from Neutral. $31 price target. Valuation stretched.

Centurylink ( CTL) downgraded at DA Davidson from Neutral to Underperform, DA Davidson said. $30 price target. Company cut its dividend and may see future dilution.

Davita ( DVA) downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call, as the stock is up 67% over the past 14 months. $120 price target.

EnCana ( ECA) downgraded at UBS to Neutral from Buy, UBS said. $21 price target. No longer expect a shift in strategy.

General Motors ( GM) downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. Company lacks near-term catalysts. $30 price target.

Generac ( GNRC) downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Expect organic sales growth to slow down. $29 price target.

Generac upgraded at Stifel. GNRC was upgraded from Hold to Buy, Stifel Nicolaus said. $42 price target. Stock is attractive, following a post-earnings selloff.

Huntington Bancshares ( HBAN) downgraded at Citigroup to Neutral from Buy, Citigroup said. $7.25 price target. Valuation call.

Netgear ( NTGR) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $41 price target. Company has multiple potential growth drivers for the second half of the year.

Northwestern ( NWE) downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call.

Oceaneering ( OII) downgraded at BMO to Market Perform, BMO Capital said. Valuation call, based on a $62 price target.

Pioneer Natural ( PXD) downgraded at Canaccord to Sell, Canaccord Genuity said.Valuation call, based on a $113 price target.

QEP Resources ( QEP) upgraded at Sterne Agee from to Neutral, Sterne Agee said. Outlook appears more balanced ahead of earnings.

Transocean ( RIG) downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $49 price target. Fleet downtime is increasing.

SunTrust Banks ( STI) downgraded at Jefferies to Hold from Buy, Jefferies said. $30 price target. Revenue trajectory concerns.

Triumph ( TGI) rated new Outperform at Wells. Company should see volume growth from new programs.

Urban Outfitters ( URBN) downgraded at BMO from Outperform to Market Perform, BMO Capital said. $45 price target. Anthropologie turnaround is lagging.

STOCK COMMENTS / EPS CHANGES

Alexion Pharmaceuticals ( ALXN) numbers lowered at Jefferies. Shares of ALXN now seen reaching $88, Jefferies said. Estimates also lowered on delay in Soliris launch. Hold rating.

Alpha Natural ( ANR) numbers increased at Credit Suisse. ANR estimates were raised through 2014, Credit Suisse said. Company is cutting cash costs. Neutral rating and new $10 price target.

Discovery ( DISCA) estimates, target reduced at Lazard. DISCA estimates were raised through 2014, Lazard Capital Markets said. Company is facing a higher tax rate. Buy rating and new $90 price target.

EOG Resources ( EOG) target raised at Jefferies to EOG now seen reaching $155, Jefferies said. Higher Eagle Ford potential. Buy rating.

Generac ( GNRC) numbers raised at Oppenheimer. Shares of GNRC now seen reaching $44, Oppenheimer said. Estimates also raised on positive outweighing the negatives. Outperform rating.

Incyte Corp ( INCY) numbers lowered at Jefferies. Shares of INCY now seen reaching $36, Jefferies said. Estimates also lowered on guidance take down. Buy rating.

Pharmacyclics ( PCYC) estimates, target raised at Credit Suisse. Shares of PCYC now seen reaching $90, accoridng to Credit Suisse. Estimates also increased, as Ibrutinib should drive growth. Outperform rating.

Pepsi ( PEP) estimates, target boosted at Morgan Stanley. Shares of PEP now seen reaching $81, according to Morgan Stanley. Estimates also raised, given higher organic sales growth. Overweight rating.

Qlik Technologies ( QLIK) numbers raised at Jefferies. Shares of QLIK now seen reaching $28, Jefferies said. Estimates also lowered on higher license expectations. Hold rating.

TAL International Group ( TAL) target raised at Jefferies to $46, Jefferies said. Residual value drives earnings beat. Hold rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.

If you liked this article you might like

Irma and Harvey Busted Algos; Probably Done Deals Under Trump: Best of Cramer

Your Guide to Making a Lot of Money on the Driverless Car Boom

How to Live Just Like Billionaire Warren Buffett